Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) President Joshua Isner sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Joshua Isner also recently made the following trade(s):
- On Tuesday, September 10th, Joshua Isner sold 25,811 shares of Axon Enterprise stock. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24.
Axon Enterprise Stock Performance
Shares of AXON stock opened at $601.29 on Thursday. The stock has a market capitalization of $45.85 billion, a PE ratio of 155.37, a P/E/G ratio of 14.95 and a beta of 0.94. The firm has a 50 day moving average of $428.90 and a two-hundred day moving average of $353.54. Axon Enterprise, Inc. has a 52 week low of $220.51 and a 52 week high of $624.84. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.
Wall Street Analyst Weigh In
Check Out Our Latest Research Report on Axon Enterprise
Institutional Investors Weigh In On Axon Enterprise
A number of hedge funds have recently bought and sold shares of AXON. Blue Trust Inc. raised its holdings in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares in the last quarter. Quent Capital LLC boosted its position in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares in the last quarter. Brooklyn Investment Group purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at about $41,000. Asset Dedication LLC acquired a new stake in shares of Axon Enterprise during the 2nd quarter worth about $47,000. Finally, Planning Capital Management Corp lifted its stake in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- Breakout Stocks: What They Are and How to Identify Them
- Insiders Bet Big on These Small Cap Stocks
- How to Capture the Benefits of Dividend Increases
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.